• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1外膜糖蛋白gp120的V3环内的N-连接聚糖g15影响共受体使用、细胞嗜性和中和作用。

The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization.

作者信息

Polzer Svenja, Dittmar Matthias T, Schmitz Herbert, Schreiber Michael

机构信息

Bernhard Nocht Institute for Tropical Medicine, 20359, Hamburg, Germany.

出版信息

Virology. 2002 Dec 5;304(1):70-80. doi: 10.1006/viro.2002.1760.

DOI:10.1006/viro.2002.1760
PMID:12490404
Abstract

We have studied infectivity and neutralization of X4, R5, and R5X4 tropic HIV-1 mutants, which are lacking N-linked glycosylation sites for glycans g13, g14, g15, and g17 in the V3 loop region of gp120. X4-tropic NL4-3 mutants lacking combinations of g14/15 or g15/17 showed markedly higher infectivity in CXCR4-specific infection. The role of g15 in CCR5-specific infection was investigated using viruses with high (NL-918, R5-monotropic), medium (NL-991, R5-monotropic), and low (NL-952, R5X4-dualtropic) CCR5-specific infectivity. For NL-991, a reduction of infectivity on GHOST-CCR5 cells was observed for a mutant lacking g15. For NL-952 mutants all lacking g15, a complete loss of CCR5-specificity was observed and NL-952 was shifted from R5X4 to X4 tropism. For all mutants of NL4-3, NL-991, and NL-952, where the lack of g15 markedly influenced infectivity or coreceptor usage, neutralization was enhanced. In contrast, NL-918 mutants with or without g15 showed no difference in neutralization and no difference in GHOST-CCR5 infection rates. Thus, for viruses with a low or medium CCR5-specificity the role of g15 for changing CCR5-usage and sensitivity to neutralization was more significant than for viruses with high infection rates on GHOST-CCR5 cells. Our data demonstrate that V3 glycans play an important role in the usage of CXCR4 and CCR5. The lack of g15 was relevant for a more efficient use of CXCR4, whereas interaction with CCR5 was facilitated in the presence of g15. This study also demonstrates that glycan g15 is involved in blocking of neutralizing antibodies and shifting HIV tropism from R5X4 to X4.

摘要

我们研究了X4、R5和R5X4嗜性的HIV-1突变体的感染性和中和作用,这些突变体在gp120的V3环区域缺乏与聚糖g13、g14、g15和g17相连的N-糖基化位点。缺乏g14/15或g15/17组合的X4嗜性NL4-3突变体在CXCR4特异性感染中表现出明显更高的感染性。使用具有高(NL-918,R5单嗜性)、中(NL-991,R5单嗜性)和低(NL-952,R5X4双嗜性)CCR5特异性感染性的病毒研究了g15在CCR5特异性感染中的作用。对于NL-991,观察到缺乏g15的突变体对GHOST-CCR5细胞的感染性降低。对于所有都缺乏g15的NL-952突变体,观察到CCR5特异性完全丧失,并且NL-952从R5X4嗜性转变为X4嗜性。对于NL4-3、NL-991和NL-952的所有突变体,其中缺乏g15显著影响感染性或共受体使用,中和作用增强。相比之下,有或没有g15的NL-918突变体在中和作用上没有差异,在GHOST-CCR5感染率上也没有差异。因此,对于具有低或中等CCR5特异性的病毒,g15在改变CCR5使用和中和敏感性方面的作用比在GHOST-CCR5细胞上具有高感染率的病毒更显著。我们的数据表明,V3聚糖在CXCR4和CCR5的使用中起重要作用。缺乏g15与更有效地使用CXCR4相关,而在存在g15的情况下促进了与CCR5的相互作用。这项研究还表明,聚糖g15参与中和抗体的阻断以及将HIV嗜性从R5X4转变为X4。

相似文献

1
The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization.HIV-1外膜糖蛋白gp120的V3环内的N-连接聚糖g15影响共受体使用、细胞嗜性和中和作用。
Virology. 2002 Dec 5;304(1):70-80. doi: 10.1006/viro.2002.1760.
2
Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.天然存在的碱性氨基酸取代在人类免疫缺陷病毒1型E亚型包膜V3环中对病毒共受体使用和细胞嗜性的作用。
J Virol. 1999 Jul;73(7):5520-6. doi: 10.1128/JVI.73.7.5520-5526.1999.
3
A virus-envelope paired competitive assay to study entry efficiency of human immunodeficiency virus type 1 in vitro.一种用于研究1型人类免疫缺陷病毒体外进入效率的病毒包膜配对竞争试验。
J Virol Methods. 2014 Sep 1;205:91-8. doi: 10.1016/j.jviromet.2014.05.009. Epub 2014 May 22.
4
Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1.
Glycobiology. 2001 Jan;11(1):11-9. doi: 10.1093/glycob/11.1.11.
5
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.
6
Infection of cells expressing CXCR4 mutants lacking N-glycosylation at the N-terminal extracellular domain is enhanced for R5X4-dualtropic human immunodeficiency virus type-1.对于R5X4双嗜性1型人类免疫缺陷病毒,感染在N端胞外结构域缺乏N-糖基化的CXCR4突变体表达细胞的能力增强。
BMC Infect Dis. 2002 Dec 19;2:31. doi: 10.1186/1471-2334-2-31.
7
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.在感染过程中,开关(R5 到 R5X4/X4-嗜性)和非开关(仅 R5-嗜性)HIV-1 群体之间的分子进化差异。
Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.
8
Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.人类免疫缺陷病毒1型包膜糖蛋白gp120中的复杂决定因素介导巨噬细胞的CXCR4依赖性感染。
J Virol. 2005 Nov;79(21):13250-61. doi: 10.1128/JVI.79.21.13250-13261.2005.
9
Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.V3独立结构域在双嗜性1型人类免疫缺陷病毒(HIV-1)包膜糖蛋白gp120利用CCR5共受体及病毒感染性方面的作用
Microbiol Immunol. 2001;45(7):521-30. doi: 10.1111/j.1348-0421.2001.tb02653.x.
10
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.人类免疫缺陷病毒1型包膜中有利于使用CCR5的组织特异性序列改变有助于双嗜性病毒在大脑中的持续存在。
J Virol. 2009 Jun;83(11):5430-41. doi: 10.1128/JVI.02648-08. Epub 2009 Mar 25.

引用本文的文献

1
Human Mannose Receptor 1 Attenuates HIV-1 Infectivity in a Virus Isolate-Specific Manner.人甘露糖受体 1 以病毒分离株特异性方式减弱 HIV-1 感染性。
Viruses. 2023 Oct 6;15(10):2057. doi: 10.3390/v15102057.
2
Co-receptor tropism and genetic characteristics of the V3 regions in variants of antiretroviral-naive HIV-1 infected subjects.抗逆转录病毒初治 HIV-1 感染者病毒变异株的共受体嗜性和 V3 区的遗传特征。
Epidemiol Infect. 2019 Jan;147:e181. doi: 10.1017/S0950268819000700.
3
Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism.
包膜V3环的蛋白质结构紊乱导致了1型人类免疫缺陷病毒细胞嗜性的转变。
PLoS One. 2017 Oct 19;12(10):e0185790. doi: 10.1371/journal.pone.0185790. eCollection 2017.
4
Neutralization function affected by single amino acid replacement in the HIV-1 antibody targets.HIV-1抗体靶点中单个氨基酸替换对中和功能的影响。
Bioinformation. 2015 Feb 28;11(2):57-62. doi: 10.6026/97320630011057. eCollection 2015.
5
Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.HIV-1 gp120 V3环中赖氨酸到精氨酸诱变对病毒进入效率和中和作用的影响。
PLoS One. 2015 Mar 18;10(3):e0119879. doi: 10.1371/journal.pone.0119879. eCollection 2015.
6
The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity.D-氨基酸肽 D3 降低了淀粉样纤维增强的 HIV-1 感染力。
AIDS Res Ther. 2014 Jan 14;11(1):1. doi: 10.1186/1742-6405-11-1.
7
The influence of N-linked glycans on the molecular dynamics of the HIV-1 gp120 V3 loop.N-连接聚糖对 HIV-1 gp120 V3 环分子动力学的影响。
PLoS One. 2013 Nov 26;8(11):e80301. doi: 10.1371/journal.pone.0080301. eCollection 2013.
8
Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1.利用结构生物学设计新型HIV-1包膜免疫原的最新进展。
Curr HIV Res. 2013 Sep;11(6):464-72. doi: 10.2174/1570162x113116660053.
9
Forced virus evolution reveals functional crosstalk between the disulfide bonded region and membrane proximal ectodomain region of HIV-1 gp41.强制病毒进化揭示了 HIV-1 gp41 中二硫键区域和膜近端胞外结构域之间的功能串扰。
Retrovirology. 2013 Apr 23;10:44. doi: 10.1186/1742-4690-10-44.
10
CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithm.CoRSeqV3-C:一种新的基于 HIV-1 亚型 C 特异性 V3 序列的核心受体使用预测算法。
Retrovirology. 2013 Feb 27;10:24. doi: 10.1186/1742-4690-10-24.